POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer
| Website | http://www.pointbiopharma.com |
| Employees | 59 (37 on RocketReach) |
| Founded | 2019 |
| Address | 4850 W 78th St, Indianapolis, Indiana 46268, US |
| Phone | +1 317-543-9957 |
| Technologies |
JavaScript
,
HTML
,
PHP
+28 more
(view full list)
|
| Industry | Biotechnology, Decision/Risk Analysis, Pharmaceuticals |
| Keywords | Cancer Treatment, Targeted Therapy, Nuclear Medicine, Oncology, Drug Development, Pharmaceutical, Biotechnology, Next Generation Medicine, Cancer Drugs, Precision Medicine, Molecular Imaging, Radiotherapy, Clinical Trials, Therapeutic Radiopharmaceuticals, Immunotherapy, Pharmaceutical Research |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, Bayer, AstraZeneca, Bristol Myers Squibb, Amgen, Regeneron, Lilly India +49 more (view full list) |
Looking for a particular POINT Biopharma employee's phone or email?
Matt Vincent is the Founder of POINT Biopharma.
37 people are employed at POINT Biopharma.
POINT Biopharma is based in Indianapolis, Indiana.